Most probably hoping his order @0.10 will get filled?
Finally our SP starting to reflect some of the great achievements from last year, it's very testing holding Co's with very strong fundamentals but SP
being held down for such long periods.
Let's see if this is our year...good luck to all Ltermers.
- Forums
- ASX - By Stock
- PER
- Sarepta gene therapy study missed key target in Duchennes
Sarepta gene therapy study missed key target in Duchennes, page-89
-
- There are more pages in this discussion • 325 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $90.15M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.0¢ | $177.5K | 1.730M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 136159 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 233891 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 136159 | 0.100 |
1 | 13154 | 0.099 |
1 | 13000 | 0.098 |
2 | 130927 | 0.097 |
1 | 10004 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 233891 | 3 |
0.110 | 447496 | 5 |
0.115 | 583850 | 5 |
0.120 | 381142 | 9 |
0.125 | 110429 | 2 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |